Vicki Gregory
Overview
Explore the profile of Vicki Gregory including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinopoulou V, Gordon M, Gregory V, Saadeh A, Akobeng A
Cochrane Database Syst Rev
. 2024 Mar;
3:CD015084.
PMID: 38501688
Background: People affected by ulcerative colitis (UC) are interested in dietary therapies as treatments that can improve their health and quality of life. Prebiotics are a category of food ingredients...
2.
Kammermeier J, Lamb C, Jones K, Anderson C, Baple E, Bolton C, et al.
Lancet Gastroenterol Hepatol
. 2023 Jan;
8(3):271-286.
PMID: 36634696
Genomic medicine enables the identification of patients with rare or ultra-rare monogenic forms of inflammatory bowel disease (IBD) and supports clinical decision making. Patients with monogenic IBD frequently experience extremely...
3.
Takashita E, Daniels R, Fujisaki S, Gregory V, Gubareva L, Huang W, et al.
Antiviral Res
. 2020 Feb;
175:104718.
PMID: 32004620
The global analysis of neuraminidase inhibitor (NAI) susceptibility of influenza viruses has been conducted since the 2012-13 period. In 2018 a novel cap-dependent endonuclease inhibitor, baloxavir, that targets polymerase acidic...
4.
Lackenby A, Besselaar T, Daniels R, Fry A, Gregory V, Gubareva L, et al.
Antiviral Res
. 2018 Jul;
157:38-46.
PMID: 29981793
A total of 13672 viruses, collected by World Health Organization recognised National Influenza Centres between May 2016 and May 2017, were assessed for neuraminidase inhibitor susceptibility by four WHO Collaborating...
5.
Gubareva L, Besselaar T, Daniels R, Fry A, Gregory V, Huang W, et al.
Antiviral Res
. 2017 Aug;
146:12-20.
PMID: 28802866
Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza (WHO CCs) assessed antiviral...
6.
Mossong J, Opp M, Gerloff N, Hau P, Kremer J, Lackenby A, et al.
Antiviral Res
. 2009 Aug;
84(1):91-4.
PMID: 19665488
Human cases of oseltamivir-resistant influenza A H1N1 virus emerging in 2007-2008 in Luxembourg were not associated with treatment, prophylaxis or stockpiling of oseltamivir. Following initial local seeding, oseltamivir-resistant strains spread...
7.
Van Reeth K, Gregory V, Hay A, Pensaert M
Vaccine
. 2003 Mar;
21(13-14):1375-81.
PMID: 12615433
A novel swine influenza virus, H1N2, circulates in European swine populations together with H1N1 and H3N2 viruses. This study examines whether post-infection immunity to H1N1 and/or H3N2 viruses provides cross-protection...